Target intelligence / Profile preview

Centromere protein F (CENPF)

Target
CENPF
Molecular classification
Kinetochore protein, Nuclear matrix-associated protein, Cell cycle protein, Chromosome segregation machinery, Other
01

Overview

Centromere protein F (CENPF) is a large nuclear matrix protein critical for correct chromosome segregation during mitosis[1][2][6]. It localizes to the kinetochore in late G2 and maintains association through early anaphase, then relocates to the spindle midzone and intercellular bridge before degradation[1][2][6]. CENPF is essential for the assembly and function of the kinetochore complex and proper orientation of microtubules, influencing both cell division and the formation of cellular cilia[1][2]. Mutations in CENPF disrupt cell division and ciliogenesis, causing developmental disorders such as Strømme syndrome[1][2]. Autoantibodies to CENPF are observed in some cancers and graft-versus-host disease[1][2]. CENPF's pivotal role in mitosis and cell proliferation has stimulated interest as a potential therapeutic target in oncology, but no clinically approved drugs are currently directed at CENPF[5].

Other names
CENPFCENP-Fmitosinhcp-1AH antigenKinetochore protein CENPFCENFCILD31PRO1779STROMSLEK1
02

Mechanism of action

Not applicable; no approved drugs directly modulate CENPF. Hypothetically: Cell cycle inhibition, disruption of kinetochore-microtubule interactions, mitotic blockade

03

Biological functions

Chromosome segregationKinetochore assembly and functionCell cycle progressionDNA synthesis regulationEmbryonic developmentCiliogenesis (formation of cilia)Microtubule organizationRegulation of cell proliferation and differentiationImmune modulation (dendritic cell regulation of T-cell response)
04

Disease associations

CancerStrømme syndromeGraft-versus-host diseaseCorpus callosum agenesisCardiomyopathyDevelopmental disorders
05

Safety considerations

Essential role in cell division—potential systemic toxicity if inhibitedRisk of negative developmental/cardiac side effects with loss of functionPossible immune-related adverse effects (autoantibody generation)
06

Interacting drugs

None specifically approved or named in current literature

1 more in the full profile.

07

Biomarkers

Autoantibodies against CENPF (cancer, graft-versus-host disease)Mutations in CENPF for diagnosis of Strømme syndrome

Beyond the preview

Go deeper on Centromere protein F (CENPF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centromere protein F (CENPF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call